Whole genome sequencing could benefit patients with cancer
«Our results from this relatively small pilot group of children with cancer, show how diagnosis and treatment can be improved. It suggests that offering whole genome sequencing to all children with cancer will provide more accurate information on diagnosis and prognosis», Dr Patrick Tarpey, lead scientist for solid cancer in the East Genomic Laboratory Hub, based at Cambridge University Hospitals NHS Foundation Trust, UK.
For each child, a sample of their tumor and a sample of their blood were sent to a lab where the full DNA sequence could be read. Scientists then looked for genetic differences, called variants, that might offer clues about how the cancer developed, the specific cancer type and which treatments might be most effective.
Please follow the link for more info.
Every new research begins with using of the biospecimens of adult patients and if successful – trials may also be duplicated on children.
BIOMEDICA CRO is ready to collect high-quality human biospecimens to provide with all needed samples and associated data for their preclinical studies. Please email us to start our collaboration: office@biomedica-cro.com or visit our page with relevant oncological conditions.
